Effects of serotonin in the hippocampus: How SSRIs and multimodal antidepressants might regulate pyramidal cell function

Elena Dale, Alan L. Pehrson, Theepica Jeyarajah, Yan Li, Steven C. Leiser, Gennady Smagin, Christina K. Olsen, Connie Sanchez

Research output: Contribution to journalReview article

42 Citations (Scopus)

Abstract

The hippocampus plays an important role in emotional and cognitive processing, and both of these domains are affected in patients with major depressive disorder (MDD). Extensive preclinical research and the notion that modulation of serotonin (5-HT) neurotransmission plays a key role in the therapeutic efficacy of selective serotonin reuptake inhibitors (SSRIs) support the view that 5-HT is important for hippocampal function in normal and disease-like conditions. The hippocampus is densely innervated by serotonergic fibers, and the majority of 5-HT receptor subtypes are expressed there. Furthermore, hippocampal cells often co-express multiple 5-HT receptor subtypes that can have either complementary or opposing effects on cell function, adding to the complexity of 5-HT neurotransmission. Here we review the current knowledge of how 5-HT, through its various receptor subtypes, modulates hippocampal output and the activity of hippocampal pyramidal cells in rodents. In addition, we discuss the relevance of 5-HT modulation for cognitive processing in rodents and possible clinical implications of these results in patients with MDD. Finally, we review the data on how SSRIs and vortioxetine, an antidepressant with multimodal activity, affect hippocampal function, including cognitive processing, from both a preclinical and clinical perspective.

Original languageEnglish
Pages (from-to)143-161
Number of pages19
JournalCNS Spectrums
Volume21
Issue number2
DOIs
StatePublished - 1 Apr 2016

Fingerprint

Pyramidal Cells
Serotonin Uptake Inhibitors
Antidepressive Agents
Hippocampus
Serotonin
Serotonin Receptors
Major Depressive Disorder
Synaptic Transmission
Rodentia
Cognition
Research

Keywords

  • Hippocampus
  • SSRI
  • pyramidal cell
  • serotonin
  • vortioxetine

Cite this

Dale, Elena ; Pehrson, Alan L. ; Jeyarajah, Theepica ; Li, Yan ; Leiser, Steven C. ; Smagin, Gennady ; Olsen, Christina K. ; Sanchez, Connie. / Effects of serotonin in the hippocampus : How SSRIs and multimodal antidepressants might regulate pyramidal cell function. In: CNS Spectrums. 2016 ; Vol. 21, No. 2. pp. 143-161.
@article{aa1ef3c89a0f467283864eb7974710d4,
title = "Effects of serotonin in the hippocampus: How SSRIs and multimodal antidepressants might regulate pyramidal cell function",
abstract = "The hippocampus plays an important role in emotional and cognitive processing, and both of these domains are affected in patients with major depressive disorder (MDD). Extensive preclinical research and the notion that modulation of serotonin (5-HT) neurotransmission plays a key role in the therapeutic efficacy of selective serotonin reuptake inhibitors (SSRIs) support the view that 5-HT is important for hippocampal function in normal and disease-like conditions. The hippocampus is densely innervated by serotonergic fibers, and the majority of 5-HT receptor subtypes are expressed there. Furthermore, hippocampal cells often co-express multiple 5-HT receptor subtypes that can have either complementary or opposing effects on cell function, adding to the complexity of 5-HT neurotransmission. Here we review the current knowledge of how 5-HT, through its various receptor subtypes, modulates hippocampal output and the activity of hippocampal pyramidal cells in rodents. In addition, we discuss the relevance of 5-HT modulation for cognitive processing in rodents and possible clinical implications of these results in patients with MDD. Finally, we review the data on how SSRIs and vortioxetine, an antidepressant with multimodal activity, affect hippocampal function, including cognitive processing, from both a preclinical and clinical perspective.",
keywords = "Hippocampus, SSRI, pyramidal cell, serotonin, vortioxetine",
author = "Elena Dale and Pehrson, {Alan L.} and Theepica Jeyarajah and Yan Li and Leiser, {Steven C.} and Gennady Smagin and Olsen, {Christina K.} and Connie Sanchez",
year = "2016",
month = "4",
day = "1",
doi = "10.1017/S1092852915000425",
language = "English",
volume = "21",
pages = "143--161",
journal = "CNS Spectrums",
issn = "1092-8529",
publisher = "Cambridge University Press",
number = "2",

}

Effects of serotonin in the hippocampus : How SSRIs and multimodal antidepressants might regulate pyramidal cell function. / Dale, Elena; Pehrson, Alan L.; Jeyarajah, Theepica; Li, Yan; Leiser, Steven C.; Smagin, Gennady; Olsen, Christina K.; Sanchez, Connie.

In: CNS Spectrums, Vol. 21, No. 2, 01.04.2016, p. 143-161.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Effects of serotonin in the hippocampus

T2 - How SSRIs and multimodal antidepressants might regulate pyramidal cell function

AU - Dale, Elena

AU - Pehrson, Alan L.

AU - Jeyarajah, Theepica

AU - Li, Yan

AU - Leiser, Steven C.

AU - Smagin, Gennady

AU - Olsen, Christina K.

AU - Sanchez, Connie

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The hippocampus plays an important role in emotional and cognitive processing, and both of these domains are affected in patients with major depressive disorder (MDD). Extensive preclinical research and the notion that modulation of serotonin (5-HT) neurotransmission plays a key role in the therapeutic efficacy of selective serotonin reuptake inhibitors (SSRIs) support the view that 5-HT is important for hippocampal function in normal and disease-like conditions. The hippocampus is densely innervated by serotonergic fibers, and the majority of 5-HT receptor subtypes are expressed there. Furthermore, hippocampal cells often co-express multiple 5-HT receptor subtypes that can have either complementary or opposing effects on cell function, adding to the complexity of 5-HT neurotransmission. Here we review the current knowledge of how 5-HT, through its various receptor subtypes, modulates hippocampal output and the activity of hippocampal pyramidal cells in rodents. In addition, we discuss the relevance of 5-HT modulation for cognitive processing in rodents and possible clinical implications of these results in patients with MDD. Finally, we review the data on how SSRIs and vortioxetine, an antidepressant with multimodal activity, affect hippocampal function, including cognitive processing, from both a preclinical and clinical perspective.

AB - The hippocampus plays an important role in emotional and cognitive processing, and both of these domains are affected in patients with major depressive disorder (MDD). Extensive preclinical research and the notion that modulation of serotonin (5-HT) neurotransmission plays a key role in the therapeutic efficacy of selective serotonin reuptake inhibitors (SSRIs) support the view that 5-HT is important for hippocampal function in normal and disease-like conditions. The hippocampus is densely innervated by serotonergic fibers, and the majority of 5-HT receptor subtypes are expressed there. Furthermore, hippocampal cells often co-express multiple 5-HT receptor subtypes that can have either complementary or opposing effects on cell function, adding to the complexity of 5-HT neurotransmission. Here we review the current knowledge of how 5-HT, through its various receptor subtypes, modulates hippocampal output and the activity of hippocampal pyramidal cells in rodents. In addition, we discuss the relevance of 5-HT modulation for cognitive processing in rodents and possible clinical implications of these results in patients with MDD. Finally, we review the data on how SSRIs and vortioxetine, an antidepressant with multimodal activity, affect hippocampal function, including cognitive processing, from both a preclinical and clinical perspective.

KW - Hippocampus

KW - SSRI

KW - pyramidal cell

KW - serotonin

KW - vortioxetine

UR - http://www.scopus.com/inward/record.url?scp=84940907863&partnerID=8YFLogxK

U2 - 10.1017/S1092852915000425

DO - 10.1017/S1092852915000425

M3 - Review article

C2 - 26346726

AN - SCOPUS:84940907863

VL - 21

SP - 143

EP - 161

JO - CNS Spectrums

JF - CNS Spectrums

SN - 1092-8529

IS - 2

ER -